MXCT MaxCyte, Inc
Price Chart
Executive Summary
MaxCyte reported Q4 and full-year 2025 results with total revenue of $7.3M and $33.0M, respectively, representing 16% and 15% YoY declines. Core revenue fell 22% in Q4 and 9% for the year, driven by reduced activity from SPL customers, including a 15% drop from its largest customer. The company issued 2026 guidance of $30–32M in revenue, below 2025 levels, citing ongoing headwinds, while projecting cash of at least $136M by year-end.
Key Financial Metrics
Actionable Insight
Traders should monitor whether the anticipated stabilization in SPL customer spending materializes in H2 2026. Given declining revenue, negative EPS, and downward guidance, the stock may face continued pressure unless there is a near-term inflection in core business performance or new licensing deals.
Key Facts
- Q4 2025 revenue was $7.3M, down 16% YoY; full-year 2025 revenue was $33.0M, down 15% YoY
- Core business revenue declined 22% in Q4 and 9% for the full year
- SPL Program-related revenue dropped to $3.4M in 2025 from $6.1M in 2024
- 2026 revenue guidance is $30–32M, below 2025's $33.0M, with $4M expected core revenue headwind
- Net loss widened to $44.6M in 2025 from $41.1M in 2024 despite lower operating expenses
- Cash, cash equivalents, and investments decreased to $155.6M from $190.3M at year-end 2024
Financial Impact
Revenue expected to decline further in 2026 to $30–32M from $33.0M in 2025, with core business under pressure and SPL milestones down significantly
Risk Factors
- Continued revenue decline beyond 2026 if SPL customer recovery is delayed
- Dilution risk if additional financing is required to sustain operations despite $155.6M cash balance
Market Snapshot
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3261732 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Apr 29, 2026
5w ago
|
DEFA14A
| $0.8800 $1.21 | ▲ +37.50% | ▲ +32.27% | $1.15 (+30.68%) |
|
Mar 24, 2026
11w ago
|
Press Release
| $0.6900 $0.8620 | ▼ −24.93% | ▼ −17.07% | $1.15 (−66.67%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access